| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32ef3c3693504dad3bb421400d5008b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f6989e50ce1c85efa75fcc83be1f6e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcaa6333c46f4ca25b8e2710c32fb9aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51a523b147b5becc1c589bb51a8d7347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2f7d118e90970b603ab7c7e0b8b02f3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-71 |
| filingDate |
2003-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e899ddb43edf12b8d6998fb806109cbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6724fcef119e0a25c2373ca3687aca24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c73560eff3ff0e066d6a5212b22d0e32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61c4799b3ea235af594b4c7425237410 |
| publicationDate |
2004-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004055052-A2 |
| titleOfInvention |
Nucleic acid sequences for use as biomarker for damage to the intestinal epithilum |
| abstract |
The present invention relates to a mucosal pentraxin (MPtx) and nucleic acids encoding the MPtx polypeptide, the expression of which in intestinal epithelium is down regulated in response to cytotoxic dieatary components such as herne. The MPtx nucleic acids and polypeptides may be used as biomarker for damage of the intestinal epithelium and/or as biomarker for increased risk of colon cancer. The MPtx nucleic acids and polypeptides may further be used as biomarker in assays for indentification of substances that modulate the condition of the intestinal epithelium. The invention further relates to pharmaceutical compositions comprising the MPtx nucleic acids, polypeptides or antibodies thereto for use in methods for treating a MPtx deficiency. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8287616-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018089386-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113773364-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113773364-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114369150-A |
| priorityDate |
2002-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |